Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant
Clinical trial NCT00001019 · COMPLETED
Trial details
- NCT number
- NCT00001019
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.